Professor Athimalaipet Ramanan

Honorary Professor

Paediatric Rheumatology

Level 6,
UHB Education Centre, Upper Maudlin Street BS2 8AE
(See a map)

Research summary

Randomised controlled trials of novel biological drugs in children with JIA associated uveitis. I am the Co-Chief Investigator of Sycamore Trial (RCT of adalimumab in JIA associated uveitis) funded by HTA/ARUK. I am also the Co-Chief Investigator of a trial of Tocilizumab in anti TNF refractory JIA associated uveitis.
Leading on new agents for management of refractory arthritis in collaboration with industry
Design and conduct studies in rare disease using novel study designs (Bayesian and Simon design)
Looking at diagnostic markers and new therapies for MAS or secondary HLH
Collaboration ...

Ramanan, AV, Dick, AD, Jones, AP, McKay, A, Williamson, PR, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H, Hughes, D, Woo, P, Benton, D, Edelsten, C, Beresford, MW & , 2017, ‘Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis’. New England Journal of Medicine, vol 376., pp. 1637-1646

Carter, SJ, Tattersall, RS & Ramanan, AV, 2019, ‘Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment’. Rheumatology, vol 58., pp. 5-17
Lythgoe, H, Almeida, B, Bennett, J, Bhat, C, Bilkhu, A, Brennan, M, Deepak, S, Dawson, P, Eleftheriou, D, Harrison, K, Hawley, D, Heaf, E, Leone, V, Long, E, Maltby, S, McErlane, F, Rafiq, N, Ramanan, AV, Riley, P, Rangaraj, S, Varnier, G, Wilkinson, N & Pain, CE, 2018, ‘Multi-centre national audit of juvenile localised scleroderma: Describing current UK practice in disease assessment and management’. Pediatric Rheumatology, vol 16.